Bayesian Capital Management LP bought a new position in Despegar.com, Corp. (NYSE:DESP - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 22,700 shares of the company's stock, valued at approximately $437,000.
A number of other institutional investors have also modified their holdings of the stock. Bank of America Corp DE grew its position in shares of Despegar.com by 98.8% during the 4th quarter. Bank of America Corp DE now owns 90,465 shares of the company's stock worth $1,741,000 after buying an additional 44,960 shares in the last quarter. BNP Paribas Financial Markets grew its holdings in Despegar.com by 483.3% during the 4th quarter. BNP Paribas Financial Markets now owns 75,628 shares of the company's stock worth $1,456,000 after acquiring an additional 62,662 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Despegar.com by 2,020.9% in the 4th quarter. Ameriprise Financial Inc. now owns 1,070,723 shares of the company's stock valued at $20,611,000 after purchasing an additional 1,020,238 shares in the last quarter. AQR Arbitrage LLC purchased a new stake in shares of Despegar.com in the 4th quarter worth approximately $1,186,000. Finally, TIG Advisors LLC purchased a new position in Despegar.com during the fourth quarter valued at approximately $8,275,000. 67.93% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, B. Riley lowered Despegar.com from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $17.20.
Get Our Latest Report on DESP
Despegar.com Stock Up 0.1 %
Shares of Despegar.com stock traded up $0.01 on Friday, reaching $19.46. The stock had a trading volume of 861,264 shares, compared to its average volume of 1,624,835. Despegar.com, Corp. has a 1 year low of $9.25 and a 1 year high of $19.55. The company has a 50 day moving average price of $19.17 and a 200 day moving average price of $18.27. The stock has a market capitalization of $1.63 billion, a P/E ratio of -648.67, a P/E/G ratio of 0.91 and a beta of 1.61.
Despegar.com (NYSE:DESP - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of $0.42 by ($0.61). Despegar.com had a net margin of 4.45% and a negative return on equity of 58.97%. The business had revenue of $210.30 million for the quarter, compared to analysts' expectations of $212.40 million. The company's revenue was up 8.7% on a year-over-year basis. On average, analysts forecast that Despegar.com, Corp. will post 0.87 earnings per share for the current fiscal year.
About Despegar.com
(
Free Report)
Despegar.com, Corp., an online travel company, provides a range of travel and travel-related products to leisure and corporate travelers through its websites and mobile applications in Latin America and the United States. The company operates in two segments, Travel Business and Financial Services Business.
Further Reading
Before you consider Despegar.com, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Despegar.com wasn't on the list.
While Despegar.com currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
